Skip to main content
Top
Gepubliceerd in: Nederlands Tijdschrift voor Traumachirurgie 5/2015

01-10-2015 | Origineel artikel

Osteomyelitisbehandeling door middel van bioglas

Auteur: J. Geurts

Gepubliceerd in: Nederlands Tijdschrift voor Traumachirurgie | Uitgave 5/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Osteomyelitis is een ernstige complicatie die kan optreden na electieve of acute chirurgie aan het bot. Adequate nettoyage en antibioticatherapie zijn dan noodzakelijk. Tot op heden is de gouden standaardbehandeling een tweestapsaanpak met intermittent gebruik van gentamycinegeladen kralen, die een hoge lokale antibioticavrijzetting geven. Recente ontwikkelingen hebben geleid tot een aantal nieuwe biomaterialen, zoals bioglas, die het mogelijk maken om het probleem in één stap aan te pakken. De expertise met deze nieuwe groep biomaterialen neemt met rasse schreden toe en de resultaten zijn zeer bemoedigend. Mogelijk kan daardoor de eenstapsaanpak in de nabije toekomst de gouden standaard worden. Dit artikel tracht inzicht te geven in de ontwikkeling, het werkingsmechanisme en de indicaties van het fascinerende biomateriaal, bioactief glas.
Literatuur
1.
go back to reference Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Eng J Med. 1970;282(4):198-206.CrossRef Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Eng J Med. 1970;282(4):198-206.CrossRef
2.
go back to reference Hench L. The story of Bioglass®. J Materials Sci Mat Med. 2006;17(11):967-78.CrossRef Hench L. The story of Bioglass®. J Materials Sci Mat Med. 2006;17(11):967-78.CrossRef
3.
go back to reference Andersson AH, Guizhi L, Karlsson KH. In vivo behaviour of glasses in the SiO2-Na2O-CaO-P2O5-Al2O3-B2O3 system. J Materials Sci Mat Med, 1990. 1(4): 219-227.CrossRef Andersson AH, Guizhi L, Karlsson KH. In vivo behaviour of glasses in the SiO2-Na2O-CaO-P2O5-Al2O3-B2O3 system. J Materials Sci Mat Med, 1990. 1(4): 219-227.CrossRef
4.
go back to reference Hench L. Bioceramics: From concept to clinic. J Am Ceram Soc. 1991;74(7):1487-510.CrossRef Hench L. Bioceramics: From concept to clinic. J Am Ceram Soc. 1991;74(7):1487-510.CrossRef
5.
go back to reference Valimaki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg. 2006;95(2):95-102.PubMed Valimaki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg. 2006;95(2):95-102.PubMed
6.
go back to reference Xynos ID, Hukkanen MV, Batten JJ, et al. Bioglass ® 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int. 2000;67(4):321-9.CrossRefPubMed Xynos ID, Hukkanen MV, Batten JJ, et al. Bioglass ® 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int. 2000;67(4):321-9.CrossRefPubMed
8.
go back to reference Lindfors NC, Aho AJ. Granule size and composition of bioactive glasses affect osteoconduction in rabbit. J Materials Sci Mat Med. 2003;14(4):365-72.CrossRef Lindfors NC, Aho AJ. Granule size and composition of bioactive glasses affect osteoconduction in rabbit. J Materials Sci Mat Med. 2003;14(4):365-72.CrossRef
9.
go back to reference Heikkilä JT, Aho AJ, Yli-Urpo A, et al. Bioactive glass versus hydroxylapatite in reconstruction of osteochondral defects in the rabbit. Act Orthop. 1993;64(6):678-82.CrossRef Heikkilä JT, Aho AJ, Yli-Urpo A, et al. Bioactive glass versus hydroxylapatite in reconstruction of osteochondral defects in the rabbit. Act Orthop. 1993;64(6):678-82.CrossRef
10.
go back to reference Turunen T, Peltola J, Helenius A, et al. Bioactive glass and calcium carbonate granules as filler material around titanium and bioactive glass implants in the medullar space of the rabbit tibia. Clin Oral Implants Res. 1997;8(2):96-102.CrossRefPubMed Turunen T, Peltola J, Helenius A, et al. Bioactive glass and calcium carbonate granules as filler material around titanium and bioactive glass implants in the medullar space of the rabbit tibia. Clin Oral Implants Res. 1997;8(2):96-102.CrossRefPubMed
11.
go back to reference Lindfors NC, Koski I, Heikkila JT, et al. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mat Res Part B: Appl Biomat. 2010;94B(1):157-64. Lindfors NC, Koski I, Heikkila JT, et al. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mat Res Part B: Appl Biomat. 2010;94B(1):157-64.
12.
go back to reference Penttinen RPK, et al. Cell interaction with bioactive glasses and ceramics, in bioactive glasses. Woodhead Publishing; 2011. p. 53-84. Penttinen RPK, et al. Cell interaction with bioactive glasses and ceramics, in bioactive glasses. Woodhead Publishing; 2011. p. 53-84.
13.
go back to reference Coraça-Huber DC, Fille M, Hausdorfer J, et al. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res. 32(1):175-7. Coraça-Huber DC, Fille M, Hausdorfer J, et al. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res. 32(1):175-7.
14.
go back to reference Stoor P, Söderling E, Grénman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Heamophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res. 2001;58(1):113-20.CrossRefPubMed Stoor P, Söderling E, Grénman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Heamophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res. 2001;58(1):113-20.CrossRefPubMed
15.
go back to reference Geurts J, Arts CJJ, Walenkamp GHIM. Bone graft substitutes in active or suspected infection. Contra-indicated or not? Injury, 2011. 42 Suppl 2: S82-S86.PubMed Geurts J, Arts CJJ, Walenkamp GHIM. Bone graft substitutes in active or suspected infection. Contra-indicated or not? Injury, 2011. 42 Suppl 2: S82-S86.PubMed
16.
go back to reference Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev. 2009;16(2):199-207.CrossRef Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev. 2009;16(2):199-207.CrossRef
17.
go back to reference Peltola M, Aitasalo K, Suonpää, et al. Bioactive glass S53P4 in frontal sinus obliteration: A long-term clinical experience. Head Neck. 2006;28(9):834-41.CrossRefPubMed Peltola M, Aitasalo K, Suonpää, et al. Bioactive glass S53P4 in frontal sinus obliteration: A long-term clinical experience. Head Neck. 2006;28(9):834-41.CrossRefPubMed
18.
go back to reference Sarin J, Grenman R, Aitasalo K, Pulkkinen J. Bioactive Glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol. 2012;121(9):563-9.CrossRefPubMed Sarin J, Grenman R, Aitasalo K, Pulkkinen J. Bioactive Glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol. 2012;121(9):563-9.CrossRefPubMed
19.
go back to reference Frantzen J, Rantakokko J, Aro HT, et al. Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech. 2011;24(7):455-61.CrossRefPubMed Frantzen J, Rantakokko J, Aro HT, et al. Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech. 2011;24(7):455-61.CrossRefPubMed
20.
go back to reference Lindfors NC, Hyvonen P, Nyyssonen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47(2):212-8.CrossRefPubMed Lindfors NC, Hyvonen P, Nyyssonen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47(2):212-8.CrossRefPubMed
21.
go back to reference McAndrew J, Efrimescu C, Sheehan E, Niall D. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. Ir J Med Sci. 2013;182(3):509-11.CrossRefPubMed McAndrew J, Efrimescu C, Sheehan E, Niall D. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. Ir J Med Sci. 2013;182(3):509-11.CrossRefPubMed
22.
go back to reference Heikkila J, Kukkonen J, Aho AJ, et al. Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study. J Mater Sci Mater Med. 2011;22(4):1073-80.CrossRefPubMed Heikkila J, Kukkonen J, Aho AJ, et al. Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study. J Mater Sci Mater Med. 2011;22(4):1073-80.CrossRefPubMed
Metagegevens
Titel
Osteomyelitisbehandeling door middel van bioglas
Auteur
J. Geurts
Publicatiedatum
01-10-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Nederlands Tijdschrift voor Traumachirurgie / Uitgave 5/2015
Print ISSN: 2214-8736
Elektronisch ISSN: 2214-8744
DOI
https://doi.org/10.1007/s12506-015-0028-7

Andere artikelen Uitgave 5/2015

Nederlands Tijdschrift voor Traumachirurgie 5/2015 Naar de uitgave

EditorialNotes

Editorial